Informatie:
Fout:
ID
34155
Beschrijving
Contrast-Enhanced Digital Mammography (CEDM) for Identifying a Change in Management of Women With Newly Diagnosed Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT01303419
Link
https://clinicaltrials.gov/show/NCT01303419
Trefwoorden
Versies (1)
- 14-01-19 14-01-19 -
Houder van rechten
see on clinicaltrials.gov
Geüploaded op
14 januari 2019
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Breast Cancer NCT01303419
Eligibility Breast Cancer NCT01303419
- StudyEvent: Eligibility
Similar models
Eligibility Breast Cancer NCT01303419
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
ID.1
Item
woman 21 years of age or older
boolean
ID.2
Item
the subject is able and willing to comply with study procedures and signed and dated informed consent is obtained.
boolean
ID.3
Item
newly diagnosed with breast cancer (dcis or invasive) identified through core biopsy or fine-needle aspiration (fna) within last 30 days.
boolean
ID.4
Item
will have or have had a bilateral ce-bmri performed within 30 days after the new breast cancer diagnosis.
boolean
ID.5
Item
woman who has already had a lumpectomy for the index lesion.
boolean
ID.6
Item
woman undergoing neoadjuvant chemotherapy treatment, hormone treatment or radiation therapy.
boolean
ID.7
Item
woman who is pregnant or who believe she may be pregnant.
boolean
ID.8
Item
woman who has breast implant.
boolean
ID.9
Item
woman who has a contraindication to the intravenous use of iodinated or gadolinium-chelated contrast agent (e.g., allergy to either agent or severely impaired renal function).
boolean